Silex Systems Limited (SLX) AI Stock Analysis

• Market Cap: $709.55M
• Dividend Yield: N/A
• Average Volume (3M): 1.17M
• Price to Earnings (P/E): ―
• Beta (1Y): 2.96
• Revenue Growth: 40.28%
• EPS Growth: -59.83%
• Country: AU
• Employees: 38
• Sector: Technology
• Sector Strength: 66
• Industry: Semiconductors
• EPS (TTM): -0.13
• Shares Outstanding: 238,102,720
• 10 Day Avg. Volume: 1,111,966
• 30 Day Avg. Volume: 1,166,430
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $6.43
• Price Target Upside: 105.58% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

Silex Systems Limited is currently facing significant financial and technical challenges. The company's operational inefficiencies and negative profitability are critical concerns, as reflected in its financial performance and valuation scores. Technical analysis further underscores a bearish trend. While the company has a stable balance sheet, improvements in profitability and cash flow consistency are essential for a more favorable outlook.

Silex Systems Limited Business Overview & Revenue Model

Company Description

Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser uranium enrichment technology in Australia. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also develops cREO, a semiconductor technology. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.

How the Company Makes Money

Silex Systems Limited generates revenue through licensing agreements and strategic partnerships related to its laser enrichment technology. The company licenses its SILEX technology to third parties, who then utilize it in their uranium enrichment operations. Silex receives royalties and milestone payments from these partners, which form the key revenue streams for the company. A significant partnership for Silex is with Global Laser Enrichment (GLE), a joint venture with Cameco Corporation, which aims to commercialize the SILEX technology in the United States. The success of these partnerships and the adoption of the SILEX technology in the nuclear fuel market are critical factors contributing to the company's earnings.

Silex Systems Limited Financial Statement Overview

Summary

Silex Systems Limited faces financial challenges, particularly in profitability and cash flow consistency. While revenue growth is evident, the company struggles with operational losses and fluctuating cash flows. The balance sheet is robust with low leverage, providing stability, but improvements in operational efficiency and profitability are needed.

Income Statement

Silex Systems Limited shows modest revenue growth, but consistent negative profitability indicators such as gross profit margin and net profit margin suggest ongoing operational challenges. The company has faced widening losses, as indicated by negative EBIT and EBITDA margins, impacting its ability to generate consistent earnings.

Balance Sheet

The balance sheet is relatively stable, with a strong equity position and manageable debt levels, reflected in a low debt-to-equity ratio. The high equity ratio indicates a solid capital structure, but the return on equity remains negative due to ongoing losses, suggesting room for improvement in leveraging equity investments to generate profit.

Cash Flow

Cash flow analysis reveals some improvement, with positive operating cash flow and free cash flow in the latest period. However, historical volatility and negative cash flow in previous periods highlight potential liquidity risks. The free cash flow to net income ratio indicates difficulties in converting revenues into liquid assets, although recent trends are more favorable.

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
6.11M	6.84M	4.22M	1.92M	1.65M
	Gross Profit
-5.09M	-1.98M	-2.86M	-4.42M	1.29M
	EBIT
-10.11M	-5.91M	-4.50M	-6.09M	-9.95M
	EBITDA
-22.26M	-5.52M	-4.06M	-5.58M	-8.28M
	Net Income Common Stockholders
-22.73M	-17.36M	-9.46M	-6.93M	-7.81M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
117.00M	140.74M	46.53M	19.90M	26.94M
	Total Assets
141.56M	152.20M	54.12M	24.04M	29.39M
	Total Debt
1.18M	772.14K	982.50K	38.40K	48.10K
	Net Debt
-17.71M	-2.09M	-4.05M	-6.36M	-1.57M
	Total Liabilities
9.62M	3.51M	3.57M	1.97M	1.92M
	Stockholders Equity
131.94M	148.69M	50.55M	22.07M	27.47M
Cash Flow		Free Cash Flow
5.85M	-2.43M	287.28K	-4.96M	-7.08M
	Operating Cash Flow
6.14M	-2.34M	412.64K	-4.78M	-6.84M
	Investing Cash Flow
7.56M	-114.40M	-40.06M	9.79M	5.16M
	Financing Cash Flow
2.34M	114.55M	38.20M	-199.34K	638.08K

Silex Systems Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 3.13
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SLX, the sentiment is Neutral. The current price of 3.13 is above the 20-day moving average (MA) of 2.88, below the 50-day MA of 3.47, and below the 200-day MA of 4.62, indicating a neutral trend. The MACD of -0.14 indicates Negative momentum. The RSI at 49.61 is Neutral, neither overbought nor oversold. The STOCH value of 50.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:SLX.

Silex Systems Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	60 Neutral	$10.83B	10.47	-6.71%	2.99%	7.73%	-12.97%
SLX	49 Neutral	$709.55M	―	-24.29%	―	40.28%	-59.83%
AGE	45 Neutral	AU$120.08M	―	-5.22%	―	―	―

Silex Systems Limited Corporate Events

Silex Systems Advances Uranium Enrichment Technology with Key US Government Support

Silex Systems Limited has announced progress in its SILEX laser-based uranium enrichment technology, with Global Laser Enrichment (GLE) starting TRL-6 demonstration testing in Wilmington, NC. This testing is crucial for validating large-scale enrichment performance and is expected to be completed by the end of 2025. The company is also advancing its manufacturing capabilities to support future technology readiness levels. Additionally, GLE has secured initial funding from the US Department of Energy, marking a significant milestone in its commercialization efforts and potentially paving the way for larger-scale funding to support US energy security.

Silex Systems Limited Announces Cessation of Securities

Silex Systems Limited announced the cessation of 6,000 securities, specifically options that expired on March 31, 2025, without being exercised or converted. This development may affect the company’s capital structure and could have implications for its financial strategies and stakeholder interests.

Silex Systems Director Adjusts Shareholdings Amid Strategic Moves

Silex Systems Limited announced a change in the director’s interest, specifically regarding Michael Goldsworthy’s holdings. On March 3, 2025, Goldsworthy exercised options to acquire 450,000 fully paid ordinary shares under the company’s Employee Incentive Plan. To fund the exercise of these options and cover tax liabilities, he sold 450,000 shares on the market. This transaction reflects a strategic move to optimize his holdings and manage financial obligations, potentially impacting investor perceptions and the company’s stock performance.

Silex Systems Limited Announces Quotation of New Securities

Silex Systems Limited has announced the quotation of 456,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code SLX, effective March 5, 2025. This move indicates a strategic step in the company’s financial operations, potentially enhancing its market presence and providing liquidity for shareholders.

Silex Systems Advances in Nuclear and Quantum Tech Amid Financial Losses

Silex Systems Limited reported a notable increase in revenue and other income for the half-year ended December 2024, despite a significant net loss. The company’s cash reserves decreased, reflecting ongoing investments into its SILEX technology projects. The advancements in uranium enrichment and quantum silicon production position Silex to potentially impact the nuclear fuel and quantum computing industries significantly, but the financial losses highlight the challenges and costs associated with these ambitious developments.

Silex Systems Limited Explores New Frontiers with SILEX Technology

Silex Systems Limited’s latest investor presentation highlights the ongoing development and potential commercial applications of its SILEX technology. The company’s projects, including uranium enrichment, Quantum Silicon production, and medical isotope separation, face several risks and uncertainties, including market conditions, regulatory approvals, and geopolitical factors. The success of these initiatives could significantly impact the company’s operational and industry position, although there is no guarantee of future performance.

Silex Systems Advances Uranium and Quantum Silicon Projects

Silex Systems Limited has made significant strides in its uranium enrichment technology projects during the half-year ending December 2024. Progress includes the near completion of TRL-6 testing for its SILEX technology and the strategic acquisition of a 665-acre site for the Paducah Laser Enrichment Facility. Additionally, GLE’s selection as a DOE awardee under a $3.4 billion program positions it as a potential key player in the US uranium enrichment market. Furthermore, Silex is advancing its Quantum Silicon Production Plant, with substantial financial backing from both the Federal Government’s Defence Trailblazer program and Silicon Quantum Computing Pty Ltd.